Flk-1 Inhibitors

Santa Cruz Biotechnology now offers a broad range of Flk-1 Inhibitors. Flk-1 (Fetal Liver Kinase 1), also designated vascular endothelial growth factor receptor 2 (VEGF-R2) or Kinase insert domain receptor (KDR) are high affinity receptors for vascular endothelial growth factors (VEGFs). KDR (human gene) has also been designated as CD309. Flk-1 Inhibitors offered by Santa Cruz inhibit Flk-1 and, in some cases, other type III receptor tyrosine kinases and VEGF related proteins. View detailed Flk-1 Inhibitor specifications, including Flk-1 Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.